We are live on ! Find out more
ACM

Asymmetry Capital Management Portfolio holdings

AUM $188M
1-Year Est. Return 44.72%
This Fund
S&P 500
This Quarter Est. Return
+0.21%
1 Year Est. Return
+44.72%
3 Year Est. Return
+299.95%
5 Year Est. Return
+628.83%
10 Year Est. Return
–
AUM
$73.7M
AUM Growth
-$12.6M
Cap. Flow
-$11.6M
Cap. Flow %
-15.7%
Top 10 Hldgs %
67.93%
Holding
43
New
11
Increased
8
Reduced
12
Closed
12

Top Buys

Rank Stock Value
1
OPTN
OptiNose
OPTN
+$5.64M
2
PTCT icon
PTC Therapeutics
PTCT
+$3.32M
3
DGX icon
Quest Diagnostics
DGX
+$2.41M
4
PRGO icon
Perrigo
PRGO
+$1.56M
5
AERI
Aerie Pharmaceuticals
AERI
+$1.36M

Top Sells

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$3.48M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$3.28M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$2.84M
4
HMSY
HMS Holdings Corp.
HMSY
+$2.82M
5
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
+$2.5M

Sector Composition

Rank Sector Weight
1 Healthcare 92.89%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBYI icon
26
Puma Biotechnology
PBYI
$413M
$729K 0.99%
+7,371
New +$825K
SNDX icon
27
Syndax Pharmaceuticals
SNDX
$1.76B
$539K 0.73%
+61,530
New +$609K
SNNA
28
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$484K 0.66%
26,692
-14,930
-36% -$316K
ECYT
29
DELISTED
Endocyte, Inc. Common Stock
ECYT
$349K 0.47%
+81,484
New +$388K
KALA icon
30
KALA BIO
KALA
$14.2M
$250K 0.34%
+5
New +$234K
TARA icon
31
Protara Therapeutics
TARA
$230M
$18K 0.02%
+235
New +$18.8K
ACHC icon
32
Acadia Healthcare
ACHC
$2.86B
– –
-72,889
Closed -$3.48M
INGN icon
33
Inogen
INGN
$176M
– –
-14,113
Closed -$1.34M
IONS icon
34
Ionis Pharmaceuticals
IONS
$9.06B
– –
-55,965
Closed -$2.84M
MDT icon
35
Medtronic
MDT
$110B
– –
-16,295
Closed -$1.27M
REGN icon
36
Regeneron Pharmaceuticals
REGN
$79.5B
– –
-2,233
Closed -$998K
RGNX icon
37
Regenxbio
RGNX
$722M
– –
-13,448
Closed -$443K
CLVS
38
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-14,008
Closed -$1.15M
TVTY
39
DELISTED
Tivity Health, Inc. Common Stock
TVTY
– –
-25,654
Closed -$1.05M
HMSY
40
DELISTED
HMS Holdings Corp.
HMSY
– –
-141,906
Closed -$2.82M
NITE
41
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
– –
-130,007
Closed -$2.5M
JUNO
42
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-30,760
Closed -$1.38M
CBMX
43
DELISTED
CombiMatrix Corporation
CBMX
– –
-32,641
Closed -$245K
1
2

Similar funds

FAC
Forrestal Agricultural Corporation Princeton, New Jersey $183M AUM
SWM
Strategic Wealth Management Kirkland, Washington $202M AUM 9.35% 1-Year Est. Return
MC
MRJ Capital New York $173M AUM 31.99% 1-Year Est. Return
KM
Kylin Management New York $173M AUM 39.51% 1-Year Est. Return
TI
Truehand Inc Strafford, New Hampshire $171M AUM 25.9% 1-Year Est. Return
GC
Grace Capital Quincy, Massachusetts $168M AUM 21.6% 1-Year Est. Return
REMS
Real Estate Management Services $167M AUM 37.69% 1-Year Est. Return
NM
Nokota Management New York $165M AUM

Asymmetry Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Asymmetry Capital Management held 43 positions worth $73.7M, down 15% from $86.2M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Asymmetry Capital Management withdrew a net $11.6M in Q4 2017, closing 12 positions and reducing 12 holdings. Its most notable exit was Acadia Healthcare, an estimated $3.48M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 91% a quarter earlier, followed by Industrials.

Against the trend, Asymmetry Capital Management opened a new position in OptiNose worth $5.68M.

  • Asymmetry Capital Management's largest Q4 2017 buy was OptiNose: 20,041 shares worth $5.68M.
  • Asymmetry Capital Management added most to PTC Therapeutics in Q4 2017, an estimated $3.32M increase.
  • Asymmetry Capital Management's biggest Q4 2017 reduction was Sarepta Therapeutics, cutting an estimated $3.28M.
  • Asymmetry Capital Management fully exited Acadia Healthcare in Q4 2017, selling an estimated $3.48M.
  • Asymmetry Capital Management's ten largest holdings make up 68% of its $73.7M portfolio in Q4 2017.
  • Asymmetry Capital Management opened 11 new positions and closed 12 in Q4 2017.
  • Asymmetry Capital Management's portfolio value fell 15% quarter-over-quarter to $73.7M.

Based on Asymmetry Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.